Trial Talk

The Trial Talk Podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this new series, we will hear from world-leading experts about the studies we carry out. We will get inside trials on cancer, infections, and neurodegenerative diseases, explore how public and patient involvement is shaping our studies, and discover new ways to run smarter studies.

Trial Talk is a education podcast hosted by Unknown Host, with 0 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Trial Talk, a education show with 0 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #25

  Episode 9: The ACORD collaboration: Innovative Clinical Trials for Neurodegenerative Diseases

  Aug 5, 202630 minS0

  <p>ACORD is a pioneering collaboration that brings together experts from a wide range of disciplines to accelerate the development of treatments for neurodegenerative diseases. In this episode, we explore how ACORD works in practice, the innovative methodologies that underpin it, including the multi-arm, multi-stage trial design, and the opportunities it creates for researchers at different stages of their careers. We speak with James Carpenter, one of ACORD’s founders, and Ed Jabbari, an ACORD Fellow, about the vision behind the collaboration, its potential to transform clinical research in neurodegenerative diseases, and how it has shaped Ed’s career journey. </p><p>...

  ListenShow Notes
• 

  Episode #24

  Episode 8: International Clinical Trials Methodology Conference 2024 roundup - Early Careers Edition

  Oct 31, 202425 minS0

  <p>At the start of October, lots of the Unit’s clinical trials methodology researchers travelled to Edinburgh, for the 7th International Clinical Trials Methodology Conference (ICTMC). ICTMC is the largest academic-led conference on clinical trials, bringing together trialists from across the globe to present their latest work in trials methodology. This year's conference featured a wide variety of workshops, talks and poster presentations from MRC Clinical Trials Unit researchers. I</p><p>n this latest episode of the Trial Talk podcast, four of the Unit’s early career researchers discuss the work they presented at ICTMC 2024. Gideon Darko Asamoah tell...

  ListenShow Notes
• 

  Episode #7

  Episode 7: Preventing multidrug-resistant tuberculosis

  Sep 25, 202433 minS0

  <p>In September 2024, the World Health Organization (WHO) released new guidance on preventative treatment for tuberculosis (TB). Thanks to new evidence from two randomised controlled clinical trials, the WHO now recommends that contacts of people with multidrug-resistant TB take six months of daily levofloxacin. In this episode of the Trial Talk podcast, we find out more about the TB-CHAMP and VQUIN trials. We also learn how the teams came together to combine their data and strengthen their evidence, using new statistical methodologies developed at the MRC Clinical Trials Unit at UCL. The episode features interviews with Anneke Hesseling, Principal Investigator...

  ListenShow Notes
• 

  Episode #23

  Episode 6: The OPTIC study: Patient views on optimising immunotherapy in cancer

  Jul 1, 202425 minS0

  <p>Optimisation immunotherapy clinical trials investigate ways of reducing the intensity of immunotherapy cancer treatment. This could be beneficial for patients’ quality of life. But these trials can be challenging to run, as patients may be concerned about the impact that reducing the intensity of treatment could have on the cancer.</p><p>This episode of the Trial Talk podcast focuses on the MRC Clinical Trials Unit at UCL’s OPTIC study, which explores how people with cancer feel about taking part in optimisation immunotherapy trials. Clinical Fellow Sophie Merrick discusses the main barriers that patients face and recommendations to addr...

  ListenShow Notes
• 

  Episode #22

  Episode 5: Patient and Public Involvement (PPI) in clinical trials

  Jun 4, 202435 minS0

  <p>The MRC Clinical Trials Unit at UCL is committed to actively involving patients and the public in our trials. All our Patient and Public Involvement (PPI) work is overseen by our PPI Group, made up of MRC CTU staff alongside seven patient representatives, with a wide range of experience in different areas. In this episode of the Trial Talk podcast, two members of the Unit’s PPI Group, Richard Stephens and Ian Newsome, discuss what PPI means to them; how they got involved as patient representatives in clinical research; and how the MRC CTU at UCL embeds PPI into ou...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.